Small micelle nano-drug as well as preparation method and application thereof

A micellar nano-drug technology, which is applied in drug combinations, pharmaceutical formulations, anti-tumor drugs, etc., can solve the problems of non-direct use, low bioavailability, low water solubility, etc., to promote value-added, inhibit growth and lung metastasis , the effect of high surface area/volume ratio

Pending Publication Date: 2021-09-03
SUZHOU UNIV
View PDF1 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented technology describes making tiny particles called Microsphericles that are very large with many atoms inside them. These Large Microcapsules have special properties such as being stable when suspended in water but dissolving quickly if placed near an organism's body. They also allow certain molecules within their shell to enter it easily through porous membranes made from materials like silicon dioxane. Overall these technical features make this material ideal for delivering therapeutic agents specifically towards brain tumours.

Problems solved by technology

The technical problem addressed in this patented text relates to finding ways to improve the properties of certain types of chemotherapeutics by reducing their poor dissolution rate when administered through traditional methods like injection into blood vessels due to insurmountable difficulties associated with delivering these compounds via other routes.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Small micelle nano-drug as well as preparation method and application thereof
  • Small micelle nano-drug as well as preparation method and application thereof
  • Small micelle nano-drug as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example

[0040] The synthesis of PEG-P(CL-DTC) block copolymer is based on MeO-PEG-OH ( M n = 2.0 kg / mol) is obtained by ring-opening polymerization of DTC and CL initiated by a macromolecular initiator and diphenyl phosphate (DPP) as a catalyst. Specifically, in an inert gas glove box, MeO-PEG-OH (800 mg, 0.4 mmol), DPP (1.0 g, 4 mmol), DTC (400 mg, 2.1 mmol), CL (400 mg, 3.5 mmol) and anhydrous DCM (3.2 mL), stirred and dissolved, sealed, removed from the glove box, and placed in a 40 ºC oil bath with magnetic stirring for 48 h. After the reaction was completed, glacial acetic acid was added to terminate the reaction, precipitated twice in 30 times the volume of glacial ether, filtered by suction, and dried in vacuum for 24 h to obtain PEG 2k -P(CL 1k -DTC 1k ), the preparation route is as follows:

[0041]

[0042] Its proton magnetic spectrum shows each characteristic peak of polymer: PEG: δ 3.38 (C H 3 O-) and 3.64 (-C H 2 C H 2 O-); DTC: δ 3.00 (-C(C H 2 SS

Embodiment 1

[0054] Example 1 Preparation and characterization of PTX micelles

[0055] Combine PTX and PEG 2k -P(CL 1k -DTC 1k ) were dissolved in PEG 350 according to different mass ratios (5 / 100, 10 / 100, 20 / 100, 30 / 100), and the polymer concentration was 50 mg / mL. After conventional ultrasonication for 5 min, 100 mL of the mixed solution was poured into the bottom of 900 mL of PB solution (pH 7.4, 10 mM) at 37 °C, and stood without stirring during the process. After injection, use a pipette gun to stick to the liquid surface and pipette 5 times to obtain a theoretical PTX drug loading of 4.8 wt. %~23.1 wt. % micellar MPTX, which is a non-targeting small micellar nanomedicine. The particle size and particle size distribution (PDI) were determined by DLS, and the micelle morphology was determined by TEM. MPTX was dissolved in acetonitrile containing 20 mM DTT (the polymer concentration was 0.1 mg / mL), and then the PTX concentration was tested by HPLC, and the drug loading a

Embodiment 2

[0066] Example 2 Preparation and property research of various PTX micelles

[0067] The targeting micelles loaded with PTX are composed of amphiphilic block polymer PEG 2k -P(CL 1k -DTC 1k ) and the polymer Ta-PEG-P (CL-DTC) coupled with targeting molecules (Ta is the polypeptide cRGD, ATN1 or ATN2) are self-assembled in the aqueous phase. 2.5%, 5%, 7.5%, 10% or 20% of ATN1-PEG-P (CL-DTC), ATN2-PEG-P (CL -DTC) or cRGD-PEG-P (CL-DTC) as the initial polymer solution, then mixed with the PTX solution, all the other steps are the same as in Example 1, to obtain micelles ATN1-MPTX, ATN2-MPTX of different polypeptide surface densities and cRGD-MPTX, targeting small micellar nanomedicines.

[0068] After mixing PEG-(CL-DTC) and targeting polymers coupled with cRGD, PHSCNK or PhScNK in different proportions, targeting micelles were prepared, and the same method as in Example 1 was used to keep the PTX drug loading at 4.8 wt. %, three series of micellar cRGD-MPTX, ATN1-MPTX and ATN2-

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention discloses a small micelle nano-drug and a preparation method and application thereof. A micromolecule drug and an amphiphilic polymer/targeted amphiphilic polymer are added into polycthylene glycol oilgomers to obtain a mixed solution, then the mixed solution is added into a buffer solution to obtain the small micelle nano-drug; and the molecular weight of the polycthylene glycol oilgomers is 200-600. The invention designs and prepares an efficient paclitaxel PTX-loaded micelle MPTX, a disulfide cross-linked micelle MPTX and three TNBC active targeting micelle nano-drug, the drug loading capacity is up to 23.1 wt.%, the particle size is less than 40 nm, and the micelle nano-drug has good stability and drug release performance of reduction response.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner SUZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products